Peak Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
PKPH Peak Pharmaceuticals Inc
CSTL Castle Biosciences Inc
GIC Global Industrial Co
EQHA EQ Health Acquisition Corp
DLCAW Deep Lake Capital Acquisition Equity Warrant Exp 04 Jan 2026 *W EXP 01/04/2026
CDK CDK Global Inc
CNC Centene Corp
ONXXF Ontex Group NV
INDB Independent Bank Corp (Massachusetts)
IIII Insu Acquisition Corp III
Go

Health Care : Biotechnology |
Company profile

Peak Pharmaceuticals, Inc. is a blank check company. The Company is seeking other business lines. The Company neither engaged in any business nor generating any revenue.

Closing Price
$0.055
Day's Change
-0.0113 (-16.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.07
Day's Low
0.0535
Volume
(Light)
Volume:
10,186

10-day average volume:
29,216
10,186
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

The risk of loss in trading futures can be substantial. Clients must consider all relevant risk factors, including their own personal financial situation, before trading. Margin and level 2 options approval or higher is required. Not all account owners will qualify.

Dividends are converted to USD using the current rate of exchange at the end of the business day on the day the dividend went EX. Earnings are converted to USD using the current rate of exchange at the end of the business day on the day earnings were announced.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.